Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
CD57 Antibody (NK-1), Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP2443520.2MG
Description
Ensure accurate, reproducible results in Immunohistochemistry (Paraffin), Immunofluorescence
beta-1,3-Glucuronyltransferase 1/B3GAT1 Monoclonal antibody specifically detects beta-1,3-Glucuronyltransferase 1/B3GAT1 in Human, Rat (Negative) samples. It is validated for Immunohistochemistry-Paraffin, Immunofluorescence.Specifications
beta-1,3-Glucuronyltransferase 1/B3GAT1 | |
Monoclonal | |
0.2mg/mL | |
Immunohistochemistry-Paraffin 2 - 4 ug/ml, Immunofluorescence 0.5 - 1 ug/ml | |
Q9P2W7 | |
B3GAT1 | |
Human peripheral blood mononuclear cells | |
0.2 mg | |
Cancer, Immunology | |
27087 | |
Human, Rat (Negative) | |
Purified |
Immunohistochemistry (Paraffin), Immunofluorescence | |
NK-1 | |
Unconjugated | |
10mM PBS and 0.05% BSA with 0.05% Sodium Azide | |
Beta-1,3-glucuronyltransferase 1, beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P), EC 2.4.1.135, galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1, GlcAT-P, GLCATPGLCUATP, glcUAT-P, Glucuronosyltransferase P, NK1, NK-1, UDP-GlcUA:glycoprotein beta-1,3-glucuronyltransferase | |
Mouse | |
Protein A or G purified | |
RUO | |
Primary | |
Anti-CD57 marks a subset of lymphocytes known as natural killer (NK) cells. Follicular center cell lymphomas often contain many NK cells within the neoplastic follicles. Anti-CD57 also stains neuroendocrine cells and their derived tumors, including carcinoid tumor and medulloblastoma. Anti-CD57 can also be useful in separating type B3 thymoma from thymic carcinoma when combined with a panel that includes antibodies against GLUT1, CD5, and CEA. | |
Store at 4C. | |
IgM κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction